We are live on ! Find out more
ESMC

Escalon Medical Corp
ESMC

Delisted

ESMC was delisted on the 17th of November, 2016.

8 hedge funds and large institutions have $893K invested in Escalon Medical Corp in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $760K → $893K (+$133K)

20% less funds holding

Funds holding: 108 (-2)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ESMC Hedge Fund Activity: Q3 2013 in Review

8 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Escalon Medical Corp (ESMC) for Q3 2013, worth a combined $893K — up 18% from $760K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ESMC and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $53K. The largest seller was Citadel Advisors, exiting entirely with an estimated $13K sold.

  • 8 institutional investors held Escalon Medical Corp (ESMC) as of Q3 2013, down from 10 in Q2 2013.
  • Funds reported $893K of Escalon Medical Corp stock for Q3 2013, up 18% quarter-over-quarter.
  • 0 funds opened new Escalon Medical Corp positions in Q3 2013 and 2 closed out, a net change of -2 holders.
  • The largest Escalon Medical Corp buyer in Q3 2013 was Vanguard Group, an estimated $53K added.
  • The largest Escalon Medical Corp seller in Q3 2013 was Citadel Advisors, an estimated $13K sold.

Based on aggregated 13F filings for Q3 2013.